{"lastClose": 7.059999942779541, "len": 1072, "date": "2023-01-13", "alpha_1": -0.07111771408237821, "beta_1": 1.6406436998986258, "drawup_1": 1.5486725887776869, "natr_1": 12.971877181870067, "sup_1": -0.08168078750805507, "res_1": 0.697828155316265, "bullPattern_1": ["BELTHOLD"], "bearPattern_1": [], "rsi_1": 36.396609785426136, "adx_1": 55.20758294959782, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.33041043127081743, "stratHoldAlpha_1": 250.7736589540113, "stratHoldDrawdown_1": -0.6265822982667562, "alpha_3mo": -0.9344522506645859, "beta_3mo": 1.6822316462384783, "drawup_3mo": 0.256227773406299, "natr_3mo": 12.971877181870067, "sup_3mo": -0.32436262597151905, "res_3mo": 0.002832881024692935, "bullPattern_3mo": [], "bearPattern_3mo": ["STALLEDPATTERN"], "rsi_3mo": 65.53845544397568, "adx_3mo": 33.9991435861833, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -1.8834133183841109, "stratHoldAlpha_3mo": 249.86321025778824, "stratHoldDrawdown_3mo": -0.4333801137539466, "Market Cap": 1018123687, "Country": "United States", "Sector": "Health Care", "IPO Year": 2018.0, "Name": "Allogene Therapeutics Inc.", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "alpha%_1": 0.5893017747030915, "beta%_1": 0.8981824990606113, "drawup%_1": 0.9992549327824385, "natr%_1": 0.9999079082672578, "drawdown%_1": 0.08338787513268336, "stratHoldSharpe%_1": 0.3297478465142444, "stratHoldAlpha%_1": 0.21487528530928324, "stratHoldDrawdown%_1": 0.07411692328378656, "alpha%_3mo": 0.060554317463148, "beta%_3mo": 0.8893514181856483, "drawup%_3mo": 0.49267030906323306, "natr%_3mo": 0.9998912252857031, "drawdown%_3mo": 0.001457548530664098, "stratHoldSharpe%_3mo": 0.020537822283885735, "stratHoldAlpha%_3mo": 0.0065389443313498, "stratHoldDrawdown%_3mo": 0.0017158814117351018}